Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice

• 主要な著者: Henry L. Blanton (著者), Melissa C. McHann (著者), Haley De Selle (著者), Canice Lei Dancel (著者), Jose-Luis Redondo (著者), Deborah Molehin (著者), Nadezhda A. German (著者), Scott Trasti (著者), Kevin Pruitt (著者), Isabel Castro-Piedras (著者), Josée Guindon (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Cannabinoid-based therapies are increasingly being used by cancer patients to treat chemotherapy-induced nausea and vomiting. Recently, cannabinoids have gained increased attention for their effects on cancer growth. Indeed, the effect of CB2 (JWH-015, JWH-133) agonists on breast cancer models have...